Oragenics, Inc. (OGEN) vs Windtree Therapeutics, Inc. (WINT)
Oragenics, Inc. and Windtree Therapeutics, Inc. are both Biotechnology companies. Oragenics, Inc. and Windtree Therapeutics, Inc. are of similar size ($2.4M and $2.3M). Windtree Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Oragenics, Inc. trades at 0.4×. Windtree Therapeutics, Inc. grew revenue faster over the last twelve months: −68.4% against −75.1%. Across the 13 metrics below, Windtree Therapeutics, Inc. leads on 8 and Oragenics, Inc. on 5.
Valuation
Profitability
| Metric | OGEN | WINT | Biotechnology median |
|---|---|---|---|
| Gross margin | 19.89% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (1,307.07%) | 1,356.23% | (57.72%) |
| Return on assets | (264.23%) | (210.34%) | (49.22%) |
| Return on invested capital | 0.00% | (386.34%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack